Investigators have devised a novel therapeutic method for treating glioblastomas post-surgery by using stem cells taken from healthy donors engineered to attack GBM-specific tumor cells. This strategy demonstrated profound efficacy in preclinical models of GBM, with 100 percent of mice living over 90 days after treatment.
Click here for original story, Scientists develop ‘off the shelf’ engineered stem cells to treat aggressive brain cancer
Source: ScienceDaily